GB202207556D0 - Flavonoid compound for use in the treatment of diseases and conditions associated with neurodegenerative dysfunction - Google Patents

Flavonoid compound for use in the treatment of diseases and conditions associated with neurodegenerative dysfunction

Info

Publication number
GB202207556D0
GB202207556D0 GBGB2207556.8A GB202207556A GB202207556D0 GB 202207556 D0 GB202207556 D0 GB 202207556D0 GB 202207556 A GB202207556 A GB 202207556A GB 202207556 D0 GB202207556 D0 GB 202207556D0
Authority
GB
United Kingdom
Prior art keywords
diseases
treatment
conditions associated
flavonoid compound
neurodegenerative dysfunction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2207556.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ontrack Therapeutics Ltd
Original Assignee
Ontrack Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ontrack Therapeutics Ltd filed Critical Ontrack Therapeutics Ltd
Priority to GBGB2207556.8A priority Critical patent/GB202207556D0/en
Publication of GB202207556D0 publication Critical patent/GB202207556D0/en
Priority to GBGB2211273.4A priority patent/GB202211273D0/en
Priority to GB2302120.7A priority patent/GB2619119A/en
Priority to PCT/GB2023/051355 priority patent/WO2023227881A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
GBGB2207556.8A 2022-05-24 2022-05-24 Flavonoid compound for use in the treatment of diseases and conditions associated with neurodegenerative dysfunction Ceased GB202207556D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GBGB2207556.8A GB202207556D0 (en) 2022-05-24 2022-05-24 Flavonoid compound for use in the treatment of diseases and conditions associated with neurodegenerative dysfunction
GBGB2211273.4A GB202211273D0 (en) 2022-05-24 2022-08-02 Compounds for use in the treatment of diseases and conditions associated with inflammation
GB2302120.7A GB2619119A (en) 2022-05-24 2023-02-14 Compounds for use in the treatment of diseases and conditions associated with neurodegenerative dysfunction
PCT/GB2023/051355 WO2023227881A1 (en) 2022-05-24 2023-05-24 Compounds for use in the treatment of diseases and conditions associated with neurodegenerative dysfunction

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2207556.8A GB202207556D0 (en) 2022-05-24 2022-05-24 Flavonoid compound for use in the treatment of diseases and conditions associated with neurodegenerative dysfunction

Publications (1)

Publication Number Publication Date
GB202207556D0 true GB202207556D0 (en) 2022-07-06

Family

ID=82220581

Family Applications (3)

Application Number Title Priority Date Filing Date
GBGB2207556.8A Ceased GB202207556D0 (en) 2022-05-24 2022-05-24 Flavonoid compound for use in the treatment of diseases and conditions associated with neurodegenerative dysfunction
GBGB2211273.4A Ceased GB202211273D0 (en) 2022-05-24 2022-08-02 Compounds for use in the treatment of diseases and conditions associated with inflammation
GB2302120.7A Pending GB2619119A (en) 2022-05-24 2023-02-14 Compounds for use in the treatment of diseases and conditions associated with neurodegenerative dysfunction

Family Applications After (2)

Application Number Title Priority Date Filing Date
GBGB2211273.4A Ceased GB202211273D0 (en) 2022-05-24 2022-08-02 Compounds for use in the treatment of diseases and conditions associated with inflammation
GB2302120.7A Pending GB2619119A (en) 2022-05-24 2023-02-14 Compounds for use in the treatment of diseases and conditions associated with neurodegenerative dysfunction

Country Status (1)

Country Link
GB (3) GB202207556D0 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210292335A1 (en) * 2018-08-07 2021-09-23 Emory University Heterocyclic Flavone Derivatives, Compositions, and Methods Related Thereto

Also Published As

Publication number Publication date
GB202302120D0 (en) 2023-03-29
GB2619119A (en) 2023-11-29
GB202211273D0 (en) 2022-09-14

Similar Documents

Publication Publication Date Title
IL288214A (en) Quinazolin-4-one derivatives useful for the treatment of braf-associated diseases and disorders
IL289167A (en) 2h-indazole derivatives and their use in the treatment of disease
IL284125A (en) Quinoline derivatives for use in the treatment of inflammation diseases
IL288882A (en) Mixture of plant extracts for use in the prevention and/or treatment of chronic inflammatory bowel diseases
EP3969125A4 (en) Use of anti-fcrn antibodies in the treatment of pemphighus and pemphigoid diseases
EP4054713A4 (en) Compositions and methods for treatment or prevention of skin diseases and disorders with lekti
IL287796A (en) Compositions and methods for the treatment of atpase-mediated diseases
IL272253A (en) Compositions and methods for treatment of inflammatory conditions and diseases of the skin
EP3913002A4 (en) Application of ecm1 in prevention and/or treatment of liver fibrosis-related diseases
EP3801587A4 (en) Acylated catechin polyphenols and methods of their use for the treatment of cancer
GB202211274D0 (en) Flavonoid compound for use in the treatment of diseases and conditions associated with neurodegenerative dysfunction
GB202207556D0 (en) Flavonoid compound for use in the treatment of diseases and conditions associated with neurodegenerative dysfunction
PT3937948T (en) Phytoecdysones and the derivatives thereof for use in the treatment of neuromuscular diseases
EP4087847A4 (en) Compositions and methods for the treatment of neurodegenerative diseases
EP4100127A4 (en) Methods for the treatment of scleroderma and related conditions
IL290192A (en) Nitenin analogue compounds and their use in the treatment of chronic and acute pain
EP4073113A4 (en) Therapeutic compositions comprising an amyloid beta antibody or vaccine for prevention and treatment of diastolic dysfunction
IL282718A (en) Compounds for use in the treatment or prophylaxis of pain, inflammation and/or autoimmunity
GB202304262D0 (en) Flavonoid compound for use in the treatment of diseases and conditions associated with movement disorders
GB202207559D0 (en) Flavonoid compound for use in the treatment of diseases and conditions associated with movement disorders
GB202217453D0 (en) Compounds for use in the treatment of diseases and conditions associated with inflammation or autoimmunity
GB202208256D0 (en) Compounds for use in the treatment of diseases and conditions associated with inflammation or autoimmunity
GB202208255D0 (en) Compounds for use in the treatment of diseases and conditions associated with inflammation or autoimmunity
EP3888655A4 (en) Therapeutic composition and treatment method for amyloid neurological diseases
IL290912A (en) Conjugates and conjugates for use in preventing or treating of brain damage and neurodegenerative diseases

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)